Pharmaceutical Gelatin Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	400 Pages	BlueWeave Consulting	July, 2023	BLWC18132054

Best Price Guarantee
Price	from $4,850
Length	400 Pages
Publisher	BlueWeave Consulting
Published Date	July, 2023
SKU	BLWC18132054

Pharmaceutical Gelatin Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Source (Porcine, Bovine Skin, Bovine Bone, Marine, Poultry); By Function (Stabilizing Agent, Thickening Agent, Gelling Agent); By Type (Type A, Type B); By Application (Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Pharmaceutical Gelatin Market Size Set to Touch USD 1.8 Billion by 2029

Global pharmaceutical gelatin market is flourishing because of the growing focus on the management of increasing prevalence of chronic illnesses, favorable properties of gelatin, and the launch of advanced pharma gelatin.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global pharmaceutical gelatin market size at USD 1.22 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global pharmaceutical gelatin market size to grow at a CAGR of 5.48% reaching a value of USD 1.76 billion by 2029. Major growth drivers for the global pharmaceutical gelatin market include an increasing need for pharmaceutical-grade gelatin, the growing prevalence of chronic illnesses, rapidly aging world population, and the progressing developments in the utilization of gelatin nanoparticles in medications and vaccines. The expanding utilization of gelatin in cosmetic applications, its inherent functionalities, as well as its biomedical applications in wound dressing and healing, gene therapy, tissue engineering, implants, and bone substitutes, are further fueling the expansion of the market. Also, the increasing progress in utilizing gelatin for drug delivery purposes is expected to propel the market expansion of pharmaceutical gelatin during the forecast period. However, shift towards non-gelatin capsules is anticipated to hinder the overall market growth.

Global Pharmaceutical Gelatin Market – Overview

Pharmaceutical gelatin, derived from collagen extracted from animal body parts, is a transparent, long-lasting, inherently tasteless, and odorless food product. It possesses a dry and brittle texture when dry, while being flexible and rubbery when moist. It finds extensive applications as a gelling agent in the pharmaceutical industry for drugs, vitamins, medicines, photographic films & documents, as well as cosmetics. The production process for hard gelatin capsules involves immersing them in a warm bath of gelatin solution, followed by drying, pinning, and cutting of cap and body components, which are then assembled for distribution. These capsules are typically filled with dry forms of pharmaceutical or supplemental products by pharmaceutical or health companies. On the other hand, the manufacturing of soft gelatin capsules begins with the creation of two sheets of soft gelatin, each passing through a die to achieve the desired capsule size and shape. During capsule production, the medication or health supplements are filled with a liquid dose simultaneously. The dose and layer can serve as binding agents to eliminate unpleasant taste and odor, while also facilitating product identification. The specific gelatin melt characteristic also plays a significant role in the controlled and rapid release of medicines. Gelatin is also utilized in the production of suppositories.

Impact of COVID-19 on Global Pharmaceutical Gelatin Market

COVID-19 pandemic adversely affected the global pharmaceutical gelatin market. Initially, the market experienced disruptions in supply chains and production capacity limitations due to lockdowns, travel restrictions, and disruptions in transportation and logistics. These challenges led to difficulties in procuring raw materials for gelatin production and resulted in limited availability of pharmaceutical gelatin. Also, the pharmaceutical industry as a whole faced delays in clinical trials, regulatory approvals, and new product launches, which indirectly affected the demand for gelatin. However, as the pandemic situation improved and healthcare systems stabilized, the global pharmaceutical gelatin market started showing positive signs of recovery. There was a renewed focus on R&D, including the development of vaccines and therapeutics, which increased the demand for gelatin. Pharmaceutical companies began diversifying their supplier base and exploring alternative sourcing options to enhance supply chain resilience. The market witnessed a gradual rebound in demand for gelatin as healthcare needs resumed, and the industry adapted to the new normal.

Global Pharmaceutical Gelatin Market – By Function

Based on function, the global pharmaceutical gelatin market is divided into Stabilizing Agent, Thickening Agent, and Gelling Agent segments. The stabilizing agent segment holds the highest share in the global pharmaceutical gelatin market. Stabilizing agents are essential components in the production of gelatin-based pharmaceutical formulations, as they help maintain the stability, integrity, and shelf life of the products. These agents prevent gelatin from undergoing degradation, aggregation, or changes in physical and chemical properties. They play a crucial role in ensuring the quality and efficacy of pharmaceutical gelatin in various applications, including capsules, coatings, and drug delivery systems. The high demand for stabilizing agents is driven by the need for reliable and consistent gelatin formulations that meet regulatory requirements and deliver optimal performance in pharmaceutical applications.

Competitive Landscape

Major players operating in the global pharmaceutical gelatin market include Gelita AG, Trobas Pharmaceutical gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, Gelco International, Norland Products Inc, Lapi Gelatine S.p.a, and Trobus Gelatine B.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Source Overview; 1.3. Market Segmentation
2. Executive Summary
3. Global Pharmaceutical Gelatin Market Insights: 3.1. Industry Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. Advantages & properties of Gelatin; 3.2.1.2. Launch of Advanced Pharma Gelatin; 3.2.2. Restraints; 3.2.2.1. Shift Towards Non-Gelatin Capsules; 3.2.3. Opportunities; 3.2.3.1. Demand of Pharma Gelatin in Developing Countries; 3.2.4. Challenges; 3.2.4.1. High Cost of Gelatins; 3.3. Technology Advancements/Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Global Pharmaceutical Gelatin Market Overview: 4.1. Market Size & Forecast, 2019–2029; 4.1.1. By Value (USD Million); 4.2. Market Share & Forecast; 4.2.1. By Source; 4.2.1.1. Porcine; 4.2.1.2. Bovine Skin; 4.2.1.3. Bovine Bone; 4.2.1.4. Marine; 4.2.1.5. Poultry; 4.2.2. By Function; 4.2.2.1. Stabilizing Agent; 4.2.2.2. Thickening Agent; 4.2.2.3. Gelling Agent; 4.2.2.4. Others; 4.2.3. By Type; 4.2.3.1. Type A; 4.2.3.2. Type B; 4.2.4. By Application; 4.2.4.1. Hard Capsules; 4.2.4.2. Softgel Capsules; 4.2.4.3. Tablets; 4.2.4.4. Absorbable Hemostats; 4.2.4.5. Others; 4.2.5. By Region; 4.2.5.1. North America; 4.2.5.2. Europe; 4.2.5.3. Asia Pacific (APAC); 4.2.5.4. Latin America (LATAM); 4.2.5.5. Middle East and Africa (MEA)
5. North America Pharmaceutical Gelatin Market: 5.1. Market Size & Forecast, 2019–2029; 5.1.1. By Value (USD Million); 5.2. Market Share & Forecast; 5.2.1. By Source; 5.2.2. By Function; 5.2.3. By Type; 5.2.4. By Application; 5.2.5. By Country; 5.2.5.1. United States; 5.2.5.1.1. By Source; 5.2.5.1.2. By Function; 5.2.5.1.3. By Type; 5.2.5.1.4. By Application; 5.2.5.2. Canada; 5.2.5.2.1. By Source; 5.2.5.2.2. By Function; 5.2.5.2.3. By Type; 5.2.5.2.4. By Application
6. Europe Pharmaceutical Gelatin Market: 6.1. Market Size & Forecast, 2019–2029; 6.1.1. By Value (USD Million); 6.2. Market Share & Forecast; 6.2.1. By Source; 6.2.2. By Function; 6.2.3. By Type; 6.2.4. By Application; 6.2.5. By Country; 6.2.5.1. Germany; 6.2.5.1.1. By Source; 6.2.5.1.2. By Function; 6.2.5.1.3. By Type; 6.2.5.1.4. By Application; 6.2.5.2. United Kingdom; 6.2.5.2.1. By Source; 6.2.5.2.2. By Function; 6.2.5.2.3. By Type; 6.2.5.2.4. By Application; 6.2.5.3. Italy; 6.2.5.3.1. By Source; 6.2.5.3.2. By Function; 6.2.5.3.3. By Type; 6.2.5.3.4. By Application; 6.2.5.4. France; 6.2.5.4.1. By Source; 6.2.5.4.2. By Function; 6.2.5.4.3. By Type; 6.2.5.4.4. By Application; 6.2.5.5. Spain; 6.2.5.5.1. By Source; 6.2.5.5.2. By Function; 6.2.5.5.3. By Type; 6.2.5.5.4. By Application; 6.2.5.6. Belgium; 6.2.5.6.1. By Source; 6.2.5.6.2. By Function; 6.2.5.6.3. By Type; 6.2.5.6.4. By Application; 6.2.5.7. Russia; 6.2.5.7.1. By Source; 6.2.5.7.2. By Function; 6.2.5.7.3. By Type; 6.2.5.7.4. By Application; 6.2.5.8. The Netherlands; 6.2.5.8.1. By Source; 6.2.5.8.2. By Function; 6.2.5.8.3. By Type; 6.2.5.8.4. By Application; 6.2.5.9. Rest of Europe; 6.2.5.9.1. By Source; 6.2.5.9.2. By Function; 6.2.5.9.3. By Type; 6.2.5.9.4. By Application
7. Asia-Pacific Pharmaceutical Gelatin Market: 7.1. Market Size & Forecast, 2019–2029; 7.1.1. By Value (USD Million); 7.2. Market Share & Forecast; 7.2.1. By Source; 7.2.2. By Function; 7.2.3. By Type; 7.2.4. By Application; 7.2.5. By Country; 7.2.5.1. China; 7.2.5.1.1. By Source; 7.2.5.1.2. By Function; 7.2.5.1.3. By Type; 7.2.5.1.4. By Application; 7.2.5.2. India; 7.2.5.2.1. By Source; 7.2.5.2.2. By Function; 7.2.5.2.3. By Type; 7.2.5.2.4. By Application; 7.2.5.3. Japan; 7.2.5.3.1. By Source; 7.2.5.3.2. By Function; 7.2.5.3.3. By Type; 7.2.5.3.4. By Application; 7.2.5.4. South Korea; 7.2.5.4.1. By Source; 7.2.5.4.2. By Function; 7.2.5.4.3. By Type; 7.2.5.4.4. By Application; 7.2.5.5. Australia & New Zealand; 7.2.5.5.1. By Source; 7.2.5.5.2. By Function; 7.2.5.5.3. By Type; 7.2.5.5.4. By Application; 7.2.5.6. Indonesia; 7.2.5.6.1. By Source; 7.2.5.6.2. By Function; 7.2.5.6.3. By Type; 7.2.5.6.4. By Application; 7.2.5.7. Malaysia; 7.2.5.7.1. By Source; 7.2.5.7.2. By Function; 7.2.5.7.3. By Type; 7.2.5.7.4. By Application; 7.2.5.8. Singapore; 7.2.5.8.1. By Source; 7.2.5.8.2. By Function; 7.2.5.8.3. By Type; 7.2.5.8.4. By Application; 7.2.5.9. Vietnam; 7.2.5.9.1. By Source; 7.2.5.9.2. By Function; 7.2.5.9.3. By Type; 7.2.5.9.4. By Application; 7.2.5.10. Rest of APAC; 7.2.5.10.1. By Source; 7.2.5.10.2. By Function; 7.2.5.10.3. By Type; 7.2.5.10.4. By Application
8. Latin America Pharmaceutical Gelatin Market: 8.1. Market Size & Forecast, 2019–2029; 8.1.1. By Value (USD Million); 8.2. Market Share & Forecast; 8.2.1. By Source; 8.2.2. By Function; 8.2.3. By Type; 8.2.4. By Application; 8.2.5. By Country; 8.2.5.1. Brazil; 8.2.5.1.1. By Source; 8.2.5.1.2. By Function; 8.2.5.1.3. By Type; 8.2.5.1.4. By Application; 8.2.5.2. Mexico; 8.2.5.2.1. By Source; 8.2.5.2.2. By Function; 8.2.5.2.3. By Type; 8.2.5.2.4. By Application; 8.2.5.3. Argentina; 8.2.5.3.1. By Source; 8.2.5.3.2. By Function; 8.2.5.3.3. By Type; 8.2.5.3.4. By Application; 8.2.5.4. Peru; 8.2.5.4.1. By Source; 8.2.5.4.2. By Function; 8.2.5.4.3. By Type; 8.2.5.4.4. By Application; 8.2.5.5. Rest of LATAM; 8.2.5.5.1. By Source; 8.2.5.5.2. By Function; 8.2.5.5.3. By Type; 8.2.5.5.4. By Application
9. Middle East & Africa Pharmaceutical Gelatin Market: 9.1. Market Size & Forecast, 2019–2029; 9.1.1. By Value (USD Million); 9.2. Market Share & Forecast; 9.2.1. By Source; 9.2.2. By Function; 9.2.3. By Type; 9.2.4. By Application; 9.2.5. By Country; 9.2.5.1. Saudi Arabia; 9.2.5.1.1. By Source; 9.2.5.1.2. By Function; 9.2.5.1.3. By Type; 9.2.5.1.4. By Application; 9.2.5.2. UAE; 9.2.5.2.1. By Source; 9.2.5.2.2. By Function; 9.2.5.2.3. By Type; 9.2.5.2.4. By Application; 9.2.5.3. Qatar; 9.2.5.3.1. By Source; 9.2.5.3.2. By Function; 9.2.5.3.3. By Type; 9.2.5.3.4. By Application; 9.2.5.4. Kuwait; 9.2.5.4.1. By Source; 9.2.5.4.2. By Function; 9.2.5.4.3. By Type; 9.2.5.4.4. By Application; 9.2.5.5. South Africa; 9.2.5.5.1. By Source; 9.2.5.5.2. By Function; 9.2.5.5.3. By Type; 9.2.5.5.4. By Application; 9.2.5.6. Nigeria; 9.2.5.6.1. By Source; 9.2.5.6.2. By Function; 9.2.5.6.3. By Type; 9.2.5.6.4. By Application; 9.2.5.7. Algeria; 9.2.5.7.1. By Source; 9.2.5.7.2. By Function; 9.2.5.7.3. By Type; 9.2.5.7.4. By Application; 9.2.5.8. Rest of MEA; 9.2.5.8.1. By Source; 9.2.5.8.2. By Function; 9.2.5.8.3. By Type; 9.2.5.8.4. By Application
10. Competitive Landscape: 10.1. List of Key Players and Their Sources; 10.2. Global Pharmaceutical Gelatin Company Market Share Analysis, 2022; 10.3. Competitive Benchmarking, By Operating Parameters; 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Pharmaceutical Gelatin Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 12.1. Gelita AG; 12.2. Trobas Pharmaceutical gelatine B.V; 12.3. Rousselot; 12.4. Weishardt; 12.5. Sterling Gelatin; 12.6. Catalent, Inc; 12.7. Nitta Pharmaceutical gelatin India Limited; 12.8. Aspire Pharmaceuticals; 12.9. Junca Gelatines; 12.10. Gelco International; 12.11. Norland Products Inc; 12.12. Lapi Gelatine S.p.a; 12.13. Trobus Gelatine B.V.; 12.14. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology: 14.1. Qualitative Research; 14.1.1. Primary & Secondary Research; 14.2. Quantitative Research; 14.3. Market Breakdown & Data Triangulation; 14.3.1. Secondary Research; 14.3.2. Primary Research; 14.4. Breakdown of Primary Research Respondents, By Region; 14.5. Assumptions & Limitations